Finance

Lists
LH:NYSE
Labcorp Holdings Inc
368,88 $
-0,51%
(-1,90) 1D
371,70 $
+0,76% (+2,82)
Pre-market
Closed: 19 նոյ, 16:00:03 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LH...
Open
371,60 $
High
372,35 $
Low
367,31 $
Mkt. cap
29,95 մլրդ
Avg. vol.
720,10 հզր
Volume
3,18 հզր
Dividend
0,78%
Quarterly dividend
0,72 $
Ex-dividend date
2026 թ. նոյ 24
P/E ratio
30,25
52-wk high
375,10 $
52-wk low
245,00 $
EPS
12,19 $
Beta
0,87
Shares outstanding
81,20 մլն
No. of employees
71 հզր
Open
371,60 $
High
372,35 $
Low
367,31 $
Mkt. cap
29,95 մլրդ
Avg. vol.
720,10 հզր
Volume
3,18 հզր
Dividend
0,78%
Quarterly dividend
0,72 $
Ex-dividend date
2026 թ. նոյ 24
P/E ratio
30,25
52-wk high
375,10 $
52-wk low
245,00 $
EPS
12,19 $
Beta
0,87
Shares outstanding
81,20 մլն
No. of employees
71 հզր
News stories
From web sources and news partners
Profile
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S. Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program. Wikipedia
About Labcorp Holdings Inc
CEOAdam H. Schechter
Employees71 հզր
Founded1978
HeadquartersBurlington, Հյուսիսային Կարոլինա, Միացյալ Նահանգներ
SectorHealth Care
IndustryHealth care provider
Analyst ratings
Based on 14 analysts giving stock ratings to LH in the past 3 months
Strong buy
Buy
11
Hold
3
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for LH in the last 3 months.
Highest
Current 368,88 $
420,00 $ (+13,86%)
Average
387,18 $ (+4,96%)
Lowest
340,00 $ (-7,83%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ann Hynes
Mizuho Securities
Buy
Maintained
400,00 $
+8,4%
11/15/2026
Unknown Analyst
HSBC
Buy
Upgraded
410,00 $
+11,1%
11/05/2026
David Westenberg
Piper Sandler
Hold
Maintained
365,00 $
-1,1%
10/30/2026
David S Macdonald
Truist Financial
Buy
Maintained
395,00 $
+7,1%
10/29/2026
Lu Li
Bank of America Securities
Buy
Reiterated
-
-
10/29/2026
Pito Chickering
Deutsche Bank
Hold
Maintained
355,00 $
-3,8%
10/29/2026
Kevin Caliendo
UBS
Buy
Reiterated
420,00 $
+13,9%
10/29/2026
Erin Wright
Morgan Stanley
Buy
Reiterated
388,00 $
+5,2%
10/30/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
396,00 $
+7,4%
10/29/2026
Luke Sergott
Barclays
Hold
Maintained
380,00 $
+3%
10/28/2026
Michael Cherny
Leerink Partners
Buy
Reiterated
410,00 $
+11,1%
10/29/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
340,00 $
-7,8%
09/11/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
09/11/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
-
-
08/26/2026
Michael Ryskin
Bank of America Securities
Buy
Reiterated
360,00 $
-2,4%
07/30/2026
David Toung
Argus Research
Buy
Maintained
310,00 $
-16%
06/02/2026
Unknown Analyst
Mizuho Securities
Buy
Reiterated
320,00 $
-13,3%
05/27/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
04/30/2026
Last report
2026 թ. հոկ 28
Fiscal period
Q3 2026
4,78 $ / 4,64 $
+2,94%beat
Revenue / Est. (USD)
3,81 մլրդ / 3,76 մլրդ
+1,35%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
3,52 մլրդ
3,54 մլրդ
3,73 մլրդ
3,81 մլրդ
Cost of goods sold
2,52 մլրդ
2,52 մլրդ
2,62 մլրդ
2,70 մլրդ
Cost of revenue
2,52 մլրդ
2,52 մլրդ
2,62 մլրդ
2,70 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
549,70 մլն
551,00 մլն
577,20 մլն
611,40 մլն
Operating expense
622,30 մլն
626,60 մլն
655,30 մլն
692,60 մլն
Total operating expenses
3,14 մլրդ
3,15 մլրդ
3,27 մլրդ
3,39 մլրդ
Operating income
370,90 մլն
387,20 մլն
456,70 մլն
415,50 մլն
Other non operating income
1,90 մլն
-600,00 հզր
-3,50 մլն
-5,40 մլն
EBT including unusual items
190,60 մլն
319,70 մլն
386,40 մլն
328,00 մլն
EBT excluding unusual items
315,20 մլն
333,20 մլն
391,50 մլն
341,40 մլն
Income tax expense
25,70 մլն
41,70 մլն
87,30 մլն
64,90 մլն
Effective tax rate
13,48%
13,04%
22,59%
19,79%
Other operating expenses
-
-
-
2,50 մլն
Net income
164,70 մլն
277,80 մլն
298,70 մլն
262,80 մլն
Net profit margin
4,68%
7,85%
8,01%
6,90%
Earnings per share
4,07
4,25
4,99
4,78
Interest and investment income
3,50 մլն
12,20 մլն
5,60 մլն
1,40 մլն
Interest expense
-55,00 մլն
-55,10 մլն
-61,10 մլն
-59,10 մլն
Net interest expenses
-51,50 մլն
-42,90 մլն
-55,50 մլն
-57,70 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
549,40 մլն
560,50 մլն
635,70 մլն
598,50 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps